Pfizer CEO to Public: Just ‘Trust’ Us on the Covid Booster

Pfizer CEO to Public: Just Trust Us on the Covid Booster

Pfizer announced its global phase 3 trial on a third dose in mid-July. That trial’s completion date is in 2022. Phase 3 results generally are required before regulatory approval.

“We are confident in this vaccine and the third dose, but you have to remember the vaccine efficacy study is still going on, so we need all the evidence to back up that,” Jerica Pitts, Pfizer’s director of global media relations, said Monday. The financial stakes are enormous: Pfizer announced in July that it expects $33.5 billion in covid-19 vaccine revenue this year.

The White House has added to the mixed messaging: Spokesperson Jen Psaki confirmed that the U.S. will buy an additional 200 million doses of the Pfizer-BioNTech vaccine for inoculating children under 12 and for possible boosters.

Public Health England & CDC Concur on Vaccine Shortcomings- Their “Power” Grossly Oversold/Overestimated + Boost the insanity

Public Health England & CDC Concur on Vaccine Shortcomings- Their “Power” Grossly Oversold/Overestimated.

The vaccine was never shown to block transmission of the originating variant. Ever. It had no sterilizing effect. Ever. This was known long before the jabs given enmasse.

Related:

Boost the insanity

As Covid cases, hospitalizations, and now deaths soar in Israel even though over 90 percent of older adults are fully vaccinated, the country is aggressively pushing a third shot.

CDC study shows 74% of people infected in Massachusetts Covid outbreak were fully vaccinated

CDC study shows 74% of people infected in Massachusetts Covid outbreak were fully vaccinated

While the delta variant continues to hit unvaccinated people the hardest, some vaccinated people could be carrying higher levels of the virus than previously understood and are potentially transmitting it to others, Walensky told reporters on a call Tuesday. She added the variant behaves “uniquely differently from past strains of the virus.”

Related:

CDC Scaled Back Hunt for Breakthrough Cases Just as the Delta Variant Grew – Bloomberg identified more than 100,000 vaccine breakthroughs